Cancer is not one file
The first thing to understand is that underwriters do not underwrite “cancer”. They underwrite a specific diagnosis, at a specific stage, with a specific treatment history, at a specific distance in time. A thyroid cancer caught early and treated with surgery is a different risk from a lung cancer diagnosed late and treated with chemotherapy; a cancer in remission for ten years is a different risk from the same cancer in remission for one year. The word on the application is the same — cancer — and the files are not.
That is why the question “can I get life insurance with cancer?” has no single answer, and why any guide that gives one is guessing. The answer depends on the file, and the file depends on six things, which the rest of this guide takes in turn: the type and location of the cancer, the stage and grade at diagnosis, the treatment received, the time since treatment ended, the current status, and the recurrence history. If you know those six things about your own history, you know what the underwriter will ask — and you can prepare the file before you apply, rather than discovering the questions one at a time.
The second thing to understand is that underwriting a cancer history takes longer than underwriting a healthy file. Underwriters request the complete medical file — pathology reports, imaging scans, surgical notes, chemotherapy or radiation records, and follow-up oncology visits — and they usually request an attending physician statement from the oncologist. Applications with a cancer history commonly take eight to twelve weeks, two to three times a standard file, largely because of the time needed to gather those records. That is not a sign that the application is going badly; it is the normal pace of a file that needs a medical director’s review.
The third thing is the route the application takes. A fully underwritten term or whole life policy offers the largest death benefits and the most competitive premiums, but it requires full medical underwriting — including exams, blood work, and a thorough review of medical records. Simplified issue and guaranteed issue policies ask fewer health questions or none at all, and they are available sooner, but they offer smaller benefits at higher premiums per dollar of cover. Which route fits depends on where you are in the timeline: during or just after treatment, the simplified routes may be the only ones open; years into remission, the fully underwritten route usually is.
What underwriters weigh — the six factors
The type and location of the cancer come first, because different cancers carry very different recurrence rates and survival outcomes. Cancers with high long-term survival — thyroid cancer, early-stage breast cancer, testicular cancer, and most non-melanoma skin cancers — are viewed more favourably than cancers with lower survival, such as lung or pancreatic cancer. That is a statement about the disease, not about the person, and it is the reason the underwriter asks for the precise diagnosis rather than the general word.
The stage and grade at diagnosis come second, and they carry most of the weight alongside the type. Underwriters use the TNM classification — the size of the primary tumour, whether cancer has reached nearby lymph nodes, and whether it has spread to distant parts of the body — to gauge severity. A localised stage I diagnosis presents a far shorter path to coverage than a stage IV case involving distant spread, and tumour grade matters too: low-grade tumours grow more slowly and signal lower risk, while high-grade tumours suggest a more aggressive disease. The pathology report is the document that carries these facts, and it is the first document the underwriter will ask for.
The treatment received comes third. Surgery alone for a localised cancer is viewed most favourably. Chemotherapy and radiation indicate a more significant case, and combination therapy more still — not because the treatment itself is a risk, but because the treatment reflects the severity of the disease it was treating. The underwriter also asks whether treatment was completed as prescribed, and whether imaging shows no evidence of disease: a partial response or ongoing treatment raises flags that a completed treatment with clean imaging does not.
The time since treatment ended comes fourth, and it is one of the single most important factors. Insurers count from the end of active therapy, not from the date of diagnosis, and they want to see a sustained period of remission before approving a traditional policy. The longer you remain cancer-free, the more favourable the rating, and many insurers use the five-year survival milestone as a benchmark — applicants who have been in remission for five years or longer often qualify for standard or near-standard rates. The waiting period varies enormously by type and stage: non-melanoma skin cancers often have little or no waiting period, early-stage prostate and thyroid cancers commonly clear sooner than more aggressive cancers, and blood cancers and metastatic disease have the longest waiting periods or may be uninsurable at standard carriers.
The current status comes fifth: remission with clean surveillance scans versus active disease or rising tumour markers. Regular oncology follow-up with clean results strengthens a file; missed appointments raise flags, even when nothing was wrong. And the recurrence history comes sixth: a single recurrence changes the file substantially, and multiple recurrences typically mean decline or postponement at standard carriers. A second primary cancer resets the clock in the same way. Both are reasons to keep the surveillance record complete and continuous, because the file the underwriter sees is the record you have kept. Heart disease and cancer are the two big questions - see life insurance with heart disease.
What to prepare before you apply
Have your oncology records organised before you apply: the pathology report, the treatment summary, and the most recent follow-up note with your oncologist’s assessment of remission status. Those three documents answer most of the underwriter’s questions, and having them ready shortens an application that is already slow. If your oncologist can provide a short letter stating the diagnosis, the stage, the treatment completed, the date treatment ended, and the current status with the most recent clean imaging, that letter is worth more than any summary you write yourself.
Disclose the history exactly as the application asks it. The contestability period — commonly the first two years, during which the insurer may investigate whether the application contained accurate information — is about honesty on the application, not about how the person died, as the site’s exclusions guide explains. An inaccurate answer about a cancer history can void a claim years later, and it will be discovered, because the insurer checks the Medical Information Bureau database, where life and health insurers share coded medical information about applicants, and requests the medical records directly.
Apply through a broker or adviser who works with multiple carriers, if you can, rather than applying to one carrier directly. The reason is the one this site’s health guides repeat: carrier selection matters more for health cases than for most others, because each carrier’s underwriting guidelines are its own, and a carrier whose oncology guidelines fit your diagnosis and timeline is worth finding before a formal application creates a record. A declined application leaves a trace that subsequent carriers will see, so the first application should be the one most likely to succeed — and that means finding the right carrier first, not the first carrier.
Consider the timing. If you are a few months from a remission milestone that matters to the carriers you are considering, waiting those months may change the outcome — and applying before the milestone does not get you a “maybe”, it gets you a decline or a postponement and a record that every subsequent carrier will see. That is a hard piece of advice to follow when cover is needed now, and it is the reason the simplified-issue route exists: if cover is needed immediately, a smaller simplified policy now, replaced or supplemented by a fully underwritten policy later, may be the honest sequence.
If the first answer is a rating, a postponement or a decline
A rating is not a rejection. It is a higher premium for the same benefit, and the size of the rating varies enormously by carrier for the same applicant — so a second and third opinion are worth the effort. That is the advice this site gives for diabetics, for high blood pressure and for seniors, and it applies with more force to cancer histories than to any other condition, because the spread between carriers is widest where the underwriting is most detailed.
A postponement is not a decline. It means the insurer wants more time — more time since treatment ended, more surveillance results, or a completed course of treatment — before it will offer terms. Ask what the postponement is waiting for, and when the insurer would reconsider: a postponement with a date is a plan, and a postponement without one is a polite decline. Use the waiting time to keep the surveillance record clean and continuous, and reapply when the condition the insurer named has been met.
A decline from one carrier is not a decline from all carriers. Each carrier’s guidelines are its own, and a history that one carrier declines may be acceptable to another at standard or near-standard rates. But a decline does leave a record, so the next application should be made with the guidance of someone who knows which carriers accept your diagnosis and timeline — not by applying to the next name on a list and hoping.
If no fully underwritten carrier will offer terms, the simplified-issue and guaranteed-issue routes remain. Simplified issue asks health questions and may check prescriptions, but requires no medical exam; guaranteed issue asks no health questions at all, but usually pays the full benefit for natural death only after about two years, with a return of premiums plus interest if death occurs earlier. Both offer smaller benefits at higher premiums per dollar than fully underwritten cover — but both offer cover, and cover that exists is better than cover that was declined.
Term, whole or universal — which shape fits after cancer
The policy type matters as much as the underwriting outcome, because the same health history can be insurable in one shape and not in another. A term policy is protection for a set number of years with no cash value, and it is the shape most people buy for income replacement — the term life hub article explains it in full. A whole life policy is permanent cover with a fixed premium and a cash value that builds gradually, explained in the whole life hub article. A universal life policy is permanent cover with flexible premiums and a cash account, explained in the universal life guide. The underwriting for all three asks the same six questions, but the answers can differ by product, because the insurer’s exposure differs: a twenty-year term policy ends, while a whole life policy is a promise for life.
For most people with a cancer history, the practical sequence is term first, if it is available, because the need that drives the purchase — replacing income while children depend on it, or covering a mortgage — is usually temporary, and term cover is the cheapest way to buy a large death benefit for a temporary need. A smaller permanent policy alongside it can carry the permanent need — final expenses, or a legacy — if permanent cover is available at a price that can be sustained. That combination is not a recommendation; it is a shape to consider, and the life needs calculator sizes the total need before the shape is chosen.
One product feature deserves attention in a cancer file above all others: conversion. A convertible term policy gives the option to convert to a permanent policy without fresh medical underwriting, and that right is worth more to someone whose health has changed than to someone whose health has not — because the alternative, applying for permanent cover later, means being underwritten again with the cancer history on the file. The conversion right is usually time-limited and may convert only into specific permanent products, so read the window and the products before you rely on it. A term policy without conversion is cheaper, and a term policy with conversion is more useful; the difference is a choice, not a detail.
Finally, consider the timing of the purchase against the timing of the cover. If the need is immediate — young children, a new mortgage — and the fully underwritten route is postponed, a simplified-issue policy now can carry the need while the waiting period runs, and a fully underwritten policy can replace or supplement it later, when the remission time has passed. That sequence costs more in total premiums than waiting, and it is worth it if the need cannot wait. If the need can wait, waiting for the remission milestone is usually the better sequence, because the fully underwritten policy will be cheaper and larger than anything the simplified route offers.
Worked example
Consider two ILLUSTRATIVE applicants. The first had a basal cell carcinoma removed five years ago, with clear margins and no recurrence. That file is close to a routine one: this site’s basal cell carcinoma guide explains that a single, fully treated lesion is often a routine file, and some carriers effectively disregard it. The second had a stage III cancer treated with surgery and chemotherapy, finishing treatment two years ago, with clean surveillance scans since. That file is a different matter: the type and stage carry weight, the treatment was extensive, and the time since treatment ended is short — so the likely outcome is a rating, or a postponement until more remission time has passed, and the carrier that offers the best terms will be the one whose oncology guidelines fit that diagnosis and timeline.
The difference between the two files is not the word “cancer”. It is the type, the stage, the treatment and the time — the six factors above, applied to two different histories. These are ILLUSTRATIVE contrasts to explain how underwriting weighs a cancer history; they predict no real person’s outcome, and no rate, waiting period or premium is asserted for either applicant.
The test to apply before you apply is the file test: do you have the pathology report, the treatment summary, and the most recent follow-up note with your oncologist’s assessment? If the answer is yes, the application can be made properly. If the answer is no, the first step is to gather those documents — because the underwriter will ask for them, and the application cannot move without them.